W. Lee, Hepatitis B Virus Infection, New England Journal of Medicine, vol.337, issue.24, pp.1733-1745, 1997.
DOI : 10.1056/NEJM199712113372406

URL : https://hal.archives-ouvertes.fr/hal-01260424

A. Lok and B. Mcmahon, Chronic hepatitis B, Hepatology, vol.34, issue.6, pp.1225-1241, 2001.
DOI : 10.1053/jhep.2001.29401

J. Tuttleman, C. Pourcel, and J. Summers, Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells, Cell, vol.47, issue.3, pp.451-460, 198647.
DOI : 10.1016/0092-8674(86)90602-1

J. Newbold, H. Xin, M. Tencza, G. Sherman, J. Dean et al., The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes, J Virol, vol.69, pp.3350-3357, 1995.

T. Wu, L. Coates, C. Aldrich, J. Summers, and W. Mason, In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway, Virology, vol.175, issue.1, pp.255-261, 1990.
DOI : 10.1016/0042-6822(90)90206-7

G. Moraleda, J. Saputelli, C. Aldrich, D. Averett, L. Condreay et al., Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus, J Virol, vol.71, pp.9392-9399, 1997.

W. Mason, J. Cullen, G. Moraleda, J. Saputelli, C. Aldrich et al., Lamivudine Therapy of WHV-Infected Woodchucks, Virology, vol.245, issue.1, pp.18-32, 1998.
DOI : 10.1006/viro.1998.9150

I. Fourel, J. Cullen, J. Saputelli, C. Aldrich, P. Schaffer et al., Evidence that hepatocyte turnover is required for rapid clearance of Duck Hepatitis B Virus during antiviral therapy of chronically infected ducks, J Virol, vol.68, pp.8321-8330, 1994.

J. Guo, H. Zhou, C. Liu, C. Aldrich, J. Saputelli et al., Apoptosis and Regeneration of Hepatocytes during Recovery from Transient Hepadnavirus Infections, Journal of Virology, vol.74, issue.3, pp.1495-1505, 2000.
DOI : 10.1128/JVI.74.3.1495-1505.2000

R. Thimme, S. Wiel, C. Steiger, J. Ghrayeb, K. Reimann et al., CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection, Journal of Virology, vol.77, issue.1, pp.68-76, 2003.
DOI : 10.1128/JVI.77.1.68-76.2003

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC140637

L. Guidotti, R. Rochford, J. Chung, M. Shapiro, R. Purcell et al., Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection, Science, vol.284, issue.5415, pp.825-829, 1999.
DOI : 10.1126/science.284.5415.825

R. Miller and W. Robinson, Hepatitis B virus DNA forms in nuclear and cytoplasmic fractions of infected human liver, Virology, vol.137, issue.2, pp.390-399, 1984.
DOI : 10.1016/0042-6822(84)90231-9

O. Yokosuka, M. Omata, F. Imazeki, K. Okuda, and J. Summers, Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: Analysis of intrahepatic replicative hepatitis B virus DNA, Hepatology, vol.27, issue.5, pp.728-734, 1985.
DOI : 10.1002/hep.1840050505

M. Dandri, M. Burda, H. Will, and J. Petersen, Increased hepatocyte turnover and inhibition of woodchuck hepatitis B virus replication by adefovirIn vitro do not lead to reduction of the closed circular DNA, Hepatology, vol.284, issue.1, pp.139-146, 2000.
DOI : 10.1053/jhep.2000.8701

J. Kock and H. Schlicht, Analysis of the earliest steps of hepadnavirus replication : genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity, J Virol, vol.67, pp.4867-4874, 1993.

P. Marcellin, T. Chang, S. Lim, M. Tong, W. Sievert et al., Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen???Positive Chronic Hepatitis B, New England Journal of Medicine, vol.348, issue.9, pp.808-816, 2003.
DOI : 10.1056/NEJMoa020681

S. Hadziyannis, N. Tassopoulos, E. Heathcote, T. Chang, G. Kitis et al., Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen???Negative Chronic Hepatitis B, New England Journal of Medicine, vol.348, issue.9, pp.800-807, 2003.
DOI : 10.1056/NEJMoa021812

M. Minami, K. Poussin, C. Brechot, and P. Paterlini, A Novel PCR Technique UsingAlu-Specific Primers to Identify Unknown Flanking Sequences from the Human Genome, Genomics, vol.29, issue.2, pp.403-408, 1995.
DOI : 10.1006/geno.1995.9004

M. Mailliard and J. Gollan, Suppressing Hepatitis B without Resistance ??? So Far, So Good, New England Journal of Medicine, vol.348, issue.9, pp.848-850, 2003.
DOI : 10.1056/NEJMe020185

C. Grandjacques, P. Pradat, L. Stuyver, M. Chevallier, P. Chevallier et al., Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity, Journal of Hepatology, vol.33, issue.3, pp.430-439, 2000.
DOI : 10.1016/S0168-8278(00)80279-2

M. Brunetto, M. Giarin, F. Oliveri, E. Chiaberge, M. Baldi et al., Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis., Proceedings of the National Academy of Sciences, vol.88, issue.10, pp.4186-4190, 1991.
DOI : 10.1073/pnas.88.10.4186

S. Hadziyannis and D. Vassilopoulos, Hepatitis B e antigen???negative chronic hepatitis B, Hepatology, vol.34, issue.4, pp.617-624, 2001.
DOI : 10.1053/jhep.2001.27834

G. Davis, J. Hoofnagle, and J. Waggoner, Spontaneous reactivation of chronic hepatitis B virus infection, Gastroenterology, vol.86, pp.230-235, 1984.

A. Lok and C. Lai, Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection, Journal of Hepatology, vol.10, issue.1, pp.29-34, 1990.
DOI : 10.1016/0168-8278(90)90069-4

M. Loriot, P. Marcellin, E. Bismuth, M. Martinot-peignoux, N. Boyer et al., Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to Anti-HBs seroconversion in patients with chronic hepatitis B, Hepatology, vol.100, issue.1, pp.32-36, 1992.
DOI : 10.1002/hep.1840150107

N. Dhedin, C. Douvin, M. Kuentz, S. Marc, M. Reman et al., REVERSE SEROCONVERSION OF HEPATITIS B AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION, Transplantation, vol.66, issue.5, pp.616-619, 1998.
DOI : 10.1097/00007890-199809150-00012

G. Lau, R. Liang, E. Chiu, C. Lee, and S. Lam, Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study, Bone Marrow Transplantation, vol.19, issue.8, pp.795-799, 1997.
DOI : 10.1038/sj.bmt.1700744

L. Castells, V. Vargas, F. Rodriguez, H. Allende, M. Buti et al., Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation, Liver Transplantation, vol.7, issue.10, pp.892-900, 2002.
DOI : 10.1053/jlts.2002.35555

B. Rehermann, C. Ferrari, C. Pasquinelli, and F. Chisari, The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T???lymphocyte response, Nature Medicine, vol.66, issue.10, pp.1104-1108, 1996.
DOI : 10.1016/0022-1759(79)90239-4

J. Dienstag, E. Schiff, T. Wright, R. Perrillo, H. Hann et al., Lamivudine as Initial Treatment for Chronic Hepatitis B in the United States, New England Journal of Medicine, vol.341, issue.17, pp.1256-1263, 1999.
DOI : 10.1056/NEJM199910213411702

C. Lai, R. Chine, N. Leung, T. Chang, R. Guan et al., A One-Year Trial of Lamivudine for Chronic Hepatitis B, New England Journal of Medicine, vol.339, issue.2, pp.61-68, 1998.
DOI : 10.1056/NEJM199807093390201

L. Guerhier, F. Pichoud, C. Jamard, C. Guerret, S. Chevallier et al., Antiviral Activity of ??-L-2',3'-Dideoxy-2',3'-Didehydro-5-Fluorocytidine in Woodchucks Chronically Infected with Woodchuck Hepatitis Virus, Antimicrobial Agents and Chemotherapy, vol.45, issue.4, pp.1065-1077, 2001.
DOI : 10.1128/AAC.45.4.1065-1077.2001

A. Nicoll, D. Colledge, J. Toole, P. Angus, R. Smallwood et al., Inhibition of duck hepatitis B virus replication by 9-(2-phosphonylmethoxyethyl)adenine, an acyclic phosphonate nucleoside analogue, Antimicrob Agents Chemother, vol.42, pp.3130-3135, 1998.

J. Delmas, O. Schorr, C. Jamard, C. Gibbs, C. Trepo et al., Inhibitory Effect of Adefovir on Viral DNA Synthesis and Covalently Closed Circular DNA Formation in Duck Hepatitis B Virus-Infected Hepatocytes In Vivo and In Vitro, Antimicrobial Agents and Chemotherapy, vol.46, issue.2, pp.425-433, 2002.
DOI : 10.1128/AAC.46.2.425-433.2002

M. Tsiang, J. Rooney, J. Toole, and C. Gibbs, Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy, Hepatology, vol.19, issue.6, pp.1863-1869, 1999.
DOI : 10.1002/hep.510290626

S. Lewin, R. Ribeiro, T. Walters, G. Lau, S. Bowden et al., Analysis of hepatitis B viral load decline under potent therapy: Complex decay profiles observed, Hepatology, vol.34, issue.5, pp.1012-1020, 2001.
DOI : 10.1053/jhep.2001.28509

T. Chun, L. Stuyver, S. Mizell, L. Ehler, J. Mican et al., Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy, Proceedings of the National Academy of Sciences, vol.278, issue.5341, pp.13193-13197, 1997.
DOI : 10.1126/science.278.5341.1291

D. Finzi, M. Hermankova, T. Pierson, L. Carruth, C. Buck et al., Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy, Science, vol.278, issue.5341, pp.1295-1300, 1997.
DOI : 10.1126/science.278.5341.1295

C. Boni, A. Bertoletti, A. Penna, A. Cavalli, M. Pilli et al., Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B., Journal of Clinical Investigation, vol.102, issue.5, pp.968-975, 1998.
DOI : 10.1172/JCI3731

C. Boni, A. Penna, G. Ogg, A. Bertoletti, M. Pilli et al., Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy, Hepatology, vol.33, issue.4, pp.963-971, 2001.
DOI : 10.1053/jhep.2001.23045

L. Guidotti, C. Eggers, A. Raney, S. Chi, J. Peters et al., In vivo regulation of hepatitis B virus replication by peroxisome proliferators, J Virol, vol.73, pp.10377-10386, 1999.

K. Kajino, A. Jilbert, J. Saputelli, C. Aldrich, J. Cullen et al., Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia infection of virtually every hepatocyte, J Virol, vol.68, pp.5792-5803, 1994.

Y. Zhang, B. Zhang, D. Theele, S. Litwin, E. Toll et al., Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver, Proceedings of the National Academy of Sciences, vol.65, issue.10, pp.12372-12377, 2003.
DOI : 10.1073/pnas.181347998

J. Summers, A. Jilbert, Y. W. Aldrich, C. Saputelli, J. Litwin et al., Hepatocyte turnover during resolution of a transient hepadnaviral infection, Proceedings of the National Academy of Sciences, vol.68, issue.12, pp.11652-11659, 2003.
DOI : 10.1053/jhep.2001.20899

M. Tsiang and G. Craig, Analysis of HBV Dynamics and its impact on Antiviral Development, Methods in Molecular Medecine